Highland Capital Management (Tennessee)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-8,901
| Closed | -$854K | – | 344 |
|
|
2021
Q3 | $854K | Sell |
8,901
-792
| -8% | -$76K | 0.05% | 252 |
|
|
2021
Q2 | $943K | Sell |
9,693
-136
| -1% | -$13.2K | 0.06% | 242 |
|
|
2021
Q1 | $956K | Sell |
9,829
-773
| -7% | -$75.2K | 0.06% | 243 |
|
|
2020
Q4 | $1.02M | Sell |
10,602
-565
| -5% | -$54.1K | 0.07% | 233 |
|
|
2020
Q3 | $1.07M | Buy |
11,167
+354
| +3% | +$34K | 0.08% | 213 |
|
|
2020
Q2 | $1.32M | Sell |
10,813
-990
| -8% | -$121K | 0.1% | 194 |
|
|
2020
Q1 | $1.02M | Buy |
+11,803
| New | +$1.02M | 0.1% | 193 |
|
|
2019
Q4 | – | Sell |
-9,858
| Closed | -$888K | – | 322 |
|
|
2019
Q3 | $888K | Buy |
+9,858
| New | +$888K | 0.07% | 224 |
|
|
2019
Q1 | – | Sell |
-8,762
| Closed | -$626K | – | 340 |
|
|
2018
Q4 | $626K | Buy |
+8,762
| New | +$626K | 0.05% | 257 |
|
|
2018
Q3 | – | Sell |
-6,554
| Closed | -$644K | – | 347 |
|
|
2018
Q2 | $644K | Buy |
+6,554
| New | +$644K | 0.05% | 263 |
|